Dong-A Pharmaceutical Co., Ltd
Records under this name other than the patents Dong-A Pharmaceutical Co., Ltd holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Back to Dong-A Pharmaceutical Co., Ltd
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,148,386 | Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,796,286 | Agent for treatment of liver diseases containing pyrazolopyrimidinone derivative Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,030,274 | Method for treating asthma and chronic obstructive pulmonary disease (COPD) comprising administering FGF2 Formerly held Term ended Term ended Jul 20, 2026 · From the USPTO record | Term ended | Term ended Jul 20, 2026 | From the USPTO record |
| US 8,242,152 | Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for the prophylaxis and treatment of osteoporosis Term ended Term ended Apr 13, 2023 · From the USPTO record | Term ended | Term ended Apr 13, 2023 | From the USPTO record |
| US 8,227,496 | Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis Term ended Term ended Apr 22, 2022 · From the USPTO record | Term ended | Term ended Apr 22, 2022 | From the USPTO record |
| US 7,662,840 | Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis Term ended Term ended Mar 29, 2022 · From the USPTO record | Term ended | Term ended Mar 29, 2022 | From the USPTO record |
| US 6,025,387 | Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease Term ended Term ended Jan 14, 2019 · From the USPTO record | Term ended | Term ended Jan 14, 2019 | From the USPTO record |
| US 7,585,979 | Process for preparing N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)-phenoxy]-pentoxy}-benzamidine Lapsed on the fee record Ended Sep 8, 2017 · From the USPTO record | Lapsed on the fee record | Ended Sep 8, 2017 | From the USPTO record |
| US 8,282,990 | Method for preparing a biodegradable polymer microsphere containing a glucose-regulating peptide Lapsed on the fee record Ended Oct 9, 2016 · From the USPTO record | Lapsed on the fee record | Ended Oct 9, 2016 | From the USPTO record |
| US 8,242,159 | 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation Lapsed on the fee record Ended Aug 14, 2016 · From the USPTO record | Lapsed on the fee record | Ended Aug 14, 2016 | From the USPTO record |